Drug · DIN 02366223
CLEVIPREX
FOR I.V. INFUSION ONLY. 50 ML AND 100 ML PRESERVATIVE-FREE, SINGLE-USE VIALS
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since August 4, 2023; first marketed August 4, 2023.
- Drug Identification Number (DIN)
- 02366223
- Company (DIN owner)
- Chiesi Farmaceutici S.P.A.Parma, Italy
- Schedule
- Prescription
- Dosage form
- Emulsion
- Route
- Intravenous
- Therapeutic class (ATC)
- clevidipine C08CA16
- Class
- Human
- Record last updated
- August 13, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| CLEVIDIPINE | 0.5 MG | ML |
Notices of Compliance
Health Canada approvals that name this DIN.
- September 29, 2016: NOC 18539New Drug Submission (NDS) · Manufacturer name change
- April 15, 2011: NOC 12270New Drug Submission (NDS)